Ramesh PR, Kumar KS, Rajagopal MR, Balachandran P, Warrier PK. Managing morphine-induced constipation: a controlled comparison of an Ayurvedic formulation and senna. Journal of Pain, Symptom Management 1998; 16:240–244.
Recchia F, Nuzzo A, Lalli A, Lombardo M, Di Lullo L, Fabiani F, et al. Randomized trial of 5-fluorouracil and high-dose folinic acid with or without alpha-2B interferon in advanced colorectal cancer. American Journal of Clinical Oncology 1996; 19:301–304.
Riley GF, Potosky AL, Lubitz JD, et al. Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Medical Care 1995; 33(8):828–841.
Ron IG, Lotan A, Inbar MJ, Chaitchik S. Advanced colorectal carcinoma: redefining the role of oral ftorafur. Anticancer Drugs 1996; 7:649–654.
Ross P, Heron J, Cunningham D. Cost of treating advanced colorectal cancer: a retrospective comparison of treatment regimens [see comments]. European Journl of Cancer 1996; 32A (Suppl)5:S13–S17.
Scheidbach H, Horbach T, Groitl H, Hohenberger W. Percutaneous endoscopic gastrostomy/ jejunostomy (PEG/PEJ) for decompression in the upper gastrointestinal tract. Initial experience with palliative treatment of gastrointestinal obstruction in terminally ill patients with advanced carcinomas. Surgical Endoscopy 1999; 13:1103–1105.
Seamans DP, Wong GY, Wilson JL. Interventional pain therapy for intractable abdominal cancer pain. Journal of Clinical Oncology 2000; 18:1598–1600.
Shah Syed GM, Maken RN, Muzzaffar N, Shah MA, Rana F. Effective and economical option for pain palliation in prostate cancer with skeletal metastases: 32P therapy revisited. NuclMedCommun 1999; 20:697–702.
Smith TJ, Hillner BE, Desch CE. Efficacy and cost-effectiveness of cancer treatment: rational allocation of resources based on decision analysis [see comments]. Journal of the National Cancer Institute 1993; 85:1460–1474.
Stommel M, Given CW, Given BA. The cost of cancer home care to families. Cancer 1993; 71: 1867–1874.
Torfs K, Pocceschi S. A retrospective study of resource utilisation in the treatment of advanced colorectal cancer in Europe. European Journal of Cancer 1996; 32A(Suppl)5:S28– 31.
Ulrich-Pur H, Kornek GV, Raderer M, Haider K, Kwasny W, Depisch D, Greul R, Schneeweiss B, Krauss G, Funovics J, Scheithauer W. A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma. Cancer 2000; 88(11): 2505–2511.
Vladeck BC. The problem isn’t payment: Medicare and the reform of end-of-life care. Generations 1999; 21:52–57.